x

TScan Therapeutics, Inc. (Nasdaq:TCRX)

Health Care/Life Sciences • Biotechnology
CIK 1783328
Company

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge, Lea Hachigian, and Tomasz Kula in 2018 and is headquartered in Boston, MA.

Address
830 Winter Street
Waltham, Massachusetts 02451
Employees
154
Stock Info
Close
$1.9200
Day Range
1.8700 - 2.0400
52 Week Range
1.8150 - 9.6900
Average volume
457.38K
Short Interest
2M (02/14/25)
% of Float Shorted
4.93%
Market Cap
$102.47M
Revenue
$21.05M
Net Income
-$89.22M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$0.9377
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chief Executive Officer & Director
Gavin MacBeath
Independent Director
Gabriela Gruia
Independent Director
Barbara J. Klencke
Independent Director
R. Keith Woods
Independent Director
Katina Dorton
Independent Director
Garry Allen Nicholson
SEC filings
DateFormEvent
16 Dec, 2024 4
10 Dec, 2024 8-K
21 Nov, 2024 8-K
19 Nov, 2024 4
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
12 Nov, 2024 8-K
12 Nov, 2024 10-Q
8 Nov, 2024 SC 13G
1 Nov, 2024 8-K
21 Oct, 2024 SC 13G
24 Sep, 2024 4
27 Aug, 2024 4
27 Aug, 2024 4
23 Aug, 2024 144
12 Aug, 2024 10-Q
12 Aug, 2024 8-K
14 Jun, 2024 8-K
14 Jun, 2024 3
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 S-8
13 May, 2024 10-Q
13 May, 2024 8-K
3 May, 2024 4
2 May, 2024 3
30 Apr, 2024 DEFA14A
30 Apr, 2024 DEF 14A
30 Apr, 2024 ARS
29 Apr, 2024 SC 13G
23 Apr, 2024 SC 13D/A
23 Apr, 2024 4
23 Apr, 2024 4
18 Apr, 2024 424B5
17 Apr, 2024 FWP
17 Apr, 2024 8-K
16 Apr, 2024 8-K
16 Apr, 2024 424B5
12 Apr, 2024 EFFECT
10 Apr, 2024 CORRESP
10 Apr, 2024 10-K/A
8 Apr, 2024 8-K
7 Mar, 2024 UPLOAD
6 Mar, 2024 S-8
6 Mar, 2024 8-K
6 Mar, 2024 S-3
6 Mar, 2024 10-K
14 Feb, 2024 SC 13G/A
9 Feb, 2024 SC 13G/A
8 Feb, 2024 SC 13G/A
7 Feb, 2024 SC 13G/A
2 Feb, 2024 4
2 Feb, 2024 3
29 Jan, 2024 8-K
21 Dec, 2023 4
18 Dec, 2023 4
11 Dec, 2023 8-K
8 Dec, 2023 3
8 Dec, 2023 4
7 Dec, 2023 8-K
9 Nov, 2023 8-K
9 Nov, 2023 10-Q
10 Aug, 2023 8-K
10 Aug, 2023 10-Q
25 Jul, 2023 8-K CEO Change
24 Jul, 2023 4
24 Jul, 2023 3
29 Jun, 2023 8-K
16 Jun, 2023 S-8
16 Jun, 2023 8-K
15 Jun, 2023 4
15 Jun, 2023 4
15 Jun, 2023 4
15 Jun, 2023 4
15 Jun, 2023 4
15 Jun, 2023 4
15 Jun, 2023 4
15 Jun, 2023 4
15 Jun, 2023 4
12 Jun, 2023 SC 13G
8 Jun, 2023 SC 13G/A
6 Jun, 2023 4
5 Jun, 2023 SC 13G
5 Jun, 2023 SC 13G
5 Jun, 2023 3
2 Jun, 2023 SC 13G
2 Jun, 2023 4
2 Jun, 2023 4
2 Jun, 2023 SC 13D/A
2 Jun, 2023 DEFA14A
2 Jun, 2023 3
31 May, 2023 8-K CEO Change
31 May, 2023 8-K
30 May, 2023 424B5
26 May, 2023 FWP
25 May, 2023 424B5
17 May, 2023 8-K
16 May, 2023 424B5
16 May, 2023 EFFECT
16 May, 2023 EFFECT
16 May, 2023 8-K
16 May, 2023 S-3/A
16 May, 2023 S-3/A
16 May, 2023 S-3/A
16 May, 2023 AW
15 May, 2023 CORRESP
15 May, 2023 144
15 May, 2023 CORRESP
10 May, 2023 CORRESP
10 May, 2023 CORRESP
10 May, 2023 10-Q
10 May, 2023 8-K
9 May, 2023 8-K
25 Apr, 2023 ARS
25 Apr, 2023 DEF 14A
25 Apr, 2023 DEFA14A
10 Apr, 2023 3
10 Apr, 2023 8-K
10 Apr, 2023 4
31 Mar, 2023 8-K CEO Change
8 Mar, 2023 10-K
8 Mar, 2023 S-8
8 Mar, 2023 8-K
14 Feb, 2023 SC 13G/A
6 Feb, 2023 4
6 Feb, 2023 4
6 Feb, 2023 4
6 Feb, 2023 4
3 Feb, 2023 SC 13G/A
23 Jan, 2023 8-K
29 Dec, 2022 4
15 Nov, 2022 UPLOAD
15 Nov, 2022 UPLOAD
9 Nov, 2022 S-3
9 Nov, 2022 8-K
9 Nov, 2022 10-Q
9 Nov, 2022 S-3
30 Sep, 2022 SC 13G
12 Sep, 2022 8-K
15 Aug, 2022 SC 13G/A
10 Aug, 2022 8-K
10 Aug, 2022 10-Q
27 Jul, 2022 4
27 Jul, 2022 4
27 Jul, 2022 4
27 Jul, 2022 4
27 Jul, 2022 4
7 Jul, 2022 3
7 Jul, 2022 4
7 Jul, 2022 8-K
3 Jun, 2022 4
3 Jun, 2022 4
3 Jun, 2022 8-K
3 Jun, 2022 4
3 Jun, 2022 4
3 Jun, 2022 4
31 May, 2022 8-K
20 May, 2022 4
12 May, 2022 10-Q
12 May, 2022 SC 13D/A
12 May, 2022 4
9 May, 2022 8-K
21 Apr, 2022 DEF 14A
21 Apr, 2022 DEFA14A
28 Mar, 2022 4
9 Mar, 2022 8-K
9 Mar, 2022 S-8
9 Mar, 2022 10-K
14 Feb, 2022 SC 13G
14 Feb, 2022 SC 13G
14 Feb, 2022 SC 13G
14 Feb, 2022 SC 13G
10 Feb, 2022 SC 13G
4 Feb, 2022 SC 13G
24 Jan, 2022 8-K
20 Jan, 2022 4
20 Jan, 2022 4
20 Jan, 2022 4
20 Jan, 2022 4
20 Jan, 2022 4
27 Dec, 2021 4
2 Dec, 2021 8-K
10 Nov, 2021 8-K
10 Nov, 2021 10-Q
27 Sep, 2021 4
22 Sep, 2021 4
22 Sep, 2021 4
13 Sep, 2021 4
9 Sep, 2021 4
9 Sep, 2021 4
9 Sep, 2021 3
31 Aug, 2021 4
19 Aug, 2021 10-Q
19 Aug, 2021 8-K
28 Jul, 2021 SC 13G
22 Jul, 2021 4
22 Jul, 2021 4
22 Jul, 2021 4
22 Jul, 2021 4
22 Jul, 2021 SC 13D
20 Jul, 2021 8-K
19 Jul, 2021 424B4 IPO completed
16 Jul, 2021 FWP
16 Jul, 2021 S-8
16 Jul, 2021 4
16 Jul, 2021 4
15 Jul, 2021 SEC STAFF
15 Jul, 2021 3
15 Jul, 2021 EFFECT
15 Jul, 2021 S-1MEF
15 Jul, 2021 CERT
15 Jul, 2021 3
15 Jul, 2021 3
15 Jul, 2021 3
15 Jul, 2021 3
15 Jul, 2021 3
15 Jul, 2021 3
15 Jul, 2021 3
15 Jul, 2021 3
15 Jul, 2021 3
15 Jul, 2021 3
14 Jul, 2021 CORRESP
13 Jul, 2021 CORRESP
13 Jul, 2021 CORRESP
13 Jul, 2021 8-A12B
13 Jul, 2021 UPLOAD
12 Jul, 2021 S-1/A
14 May, 2021 S-1/A
5 May, 2021 CORRESP
5 May, 2021 S-1/A
3 May, 2021 UPLOAD
30 Apr, 2021 CORRESP
30 Apr, 2021 S-1/A
30 Apr, 2021 CORRESP
29 Apr, 2021 UPLOAD
28 Apr, 2021 SEC STAFF
23 Apr, 2021 CORRESP
23 Apr, 2021 S-1
15 Apr, 2021 UPLOAD
12 Apr, 2021 SEC STAFF
19 Mar, 2021 DRS
28 Jan, 2021 D
Last update:2025-03-06 13:16:56.326061
TScan Therapeutics, Inc. by TradingView

Sign Up to Subscribe